Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Virpax Pharmaceuticals Inc
(NQ:
VRPX
)
0.7101
-0.0299 (-4.04%)
Streaming Delayed Price
Updated: 3:57 PM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Virpax Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
7
Next >
News Outlets Highlight Virpax Pharmaceuticals and Its Potential Solutions for the Opioid Crisis and COVID-19
February 15, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Reports Favorable Preclinical Safety Data for Envelta™ for the Treatment of Acute and Chronic Pain
February 10, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Altasciences Chosen by Virpax Pharmaceuticals, Inc. to Conduct First-in-Human Study of Epoladerm™ for Chronic Pain Associated with Osteoarthritis of the Knee
January 21, 2022
From
Altasciences and Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™
January 18, 2022
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Friday
January 14, 2022
During Friday's session, 445 companies made new 52-week lows. Noteable 52-Week Lows: Intuitive Surgical (NASDAQ:ISRG) is the largest company in terms of market cap to...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 05, 2022
Gainers SomaLogic (NASDAQ:SLGC) shares mo...
Via
Benzinga
Virpax® Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference
January 04, 2022
From
Virpax® Pharmaceuticals, Inc.
Via
Business Wire
Virpax Pharmaceuticals Recaps Milestones and Highlights Product Portfolio
December 28, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Announces Clinical Trial Site in Canada for First in Human Study of Epoladerm™ for Pain Associated with Osteoarthritis of the Knee
December 20, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
December 09, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) shares increased by 88.08% to $5.61 during Thursday's regular session. As of 12:30 EST, Ensysce Biosciences's stock is...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 09, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 08, 2021
Gainers Virpax Pharmaceuticals (NASDAQ:VRPX) shares increased by 26.54% to $5.12 during Wednesday's regular session. Trading volume for Virpax Pharmaceuticals's...
Via
Benzinga
Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm
December 08, 2021
Virpax Pharmaceuticals Inc (NASDAQ: VRPX) reported results following toxicology and pharmacokinetic study of Epoladerm to manage pain associated with...
Via
Benzinga
Virpax Reports Successful Results of Toxicology and Pharmacokinetic Study for Epoladerm™
December 08, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
4 Penny Stocks Insiders Are Buying
November 23, 2021
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste...
Via
Benzinga
Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments
November 15, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
November 10, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax Signs Agreement with Sinclair Research to Initiate Investigational New Drug (IND)-Enabling Studies for AnQlar™
October 06, 2021
From
Virpax Pharmaceuticals Inc.
Via
Business Wire
Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021
October 01, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children
September 20, 2021
From
Virpax Pharmaceuticals, Inc.
Via
Business Wire
Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock
September 16, 2021
From
Virpax Pharmaceuticals Inc.
Via
Business Wire
46 Biggest Movers From Yesterday
September 15, 2021
Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...
Via
Benzinga
Why Virpax Pharmaceuticals' Stock Is Trading Lower Today
September 14, 2021
Virpax Pharmaceuticals (NASDAQ:VRPX) shares are trading lower after the company priced a 6.67 million share common stock offering at $6 per share. Virpax Pharmaceuticals...
Via
Benzinga
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Communications Systems Shares Climb
September 14, 2021
Toward the end of trading Tuesday, the Dow traded down 0.87% to 34,565.88 while the NASDAQ fell 0.46% to 15,035.39. The S&P also fell, dropping 0.60% to 4,441.76. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Mid-Day Market Update: FuelCell Energy Jumps After Q3 Results; RedHill Biopharma Shares Slide
September 14, 2021
Midway through trading Tuesday, the Dow traded down 0.49% to 34,698.16 while the NASDAQ fell 0.05% to 15,098.38. The S&P also fell, dropping 0.24% to 4,458.05. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
36 Stocks Moving In Tuesday's Mid-Day Session
September 14, 2021
Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Lower; US Annual Inflation Rate Slows to 5.3% in August
September 14, 2021
Following the market opening Tuesday, the Dow traded down 0.26% to 34,778.27 while the NASDAQ rose 0.01% to 15,106.84. The S&P also fell, dropping 0.20% to 4,459.89. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock
September 14, 2021
From
Virpax Pharmaceuticals Inc.
Via
Business Wire
45 Stocks Moving In Monday's Mid-Day Session
September 13, 2021
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...
Via
Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.